G
Gideon Koren
Researcher at Ariel University
Publications - 2007
Citations - 88165
Gideon Koren is an academic researcher from Ariel University. The author has contributed to research in topics: Pregnancy & Population. The author has an hindex of 129, co-authored 1994 publications receiving 81718 citations. Previous affiliations of Gideon Koren include McGill University Health Centre & University of Western Ontario.
Papers
More filters
Journal ArticleDOI
Pregnant Women's Beliefs about Medications—A Study among 866 Norwegian Women
TL;DR: Most pregnant women believe that medicines in general are helpful and safe to use, however, they are much more restrictive and unsure about use during pregnancy, and health-care professionals should be aware of such attitudes.
Journal Article
Prevalence and severity of nausea and vomiting of pregnancy and effect of vitamin supplementation.
TL;DR: The relation between number of daily vomiting episodes and mean weight loss may serve as a clinical tool to assess the severity of nausea and vomiting in pregnancy and the success of anti-emetics and rehydration regimens.
Journal ArticleDOI
Safety of infliximab use during pregnancy.
TL;DR: Infliximab does not actively cross the placenta during the first trimester, but undergoes efficient placental transfer during the late second and third trimesters and is detectable in the infant's serum for several months after birth, which raises concerns about immunological risks of infection and response to vaccines.
Journal ArticleDOI
Effects of perioperative oral amantadine on postoperative pain and morphine consumption in patients after radical prostatectomy: results of a preliminary study.
TL;DR: Perioperative oral amantadine reduces postoperative opioid consumption by pharmacokinetic mechanisms, although additional pharmacodynamic interactions may also be involved.
Journal ArticleDOI
Does Paroxetine Cause Cardiac Malformations
TL;DR: First-trimester exposure to paroxetine does not appear to be associated with increased rates of cardiac malformations, and this information should be reassuring to prescribing physicians and women who require treatment with paroxETine in pregnancy.